Skip to content

Clinical trials

Phase 2 Coronary Artery Disease trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronary Artery Disease Phase: Phase 2 Country / region: China Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20161
20181
20201
20211
20222
20241
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting4
Unknown status4
Completed3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sinotau Pharmaceutical Group2
Affiliated Hospital of Nantong University1
Beijing Inno Medicine Co., Ltd.1
Dongzhimen Hospital, Beijing1
Jiangsu vcare pharmaceutical technology co., LTD1
Sirius Therapeutics Co., Ltd.1
The First Affiliated Hospital of Zhejiang Chinese Medical University1
The University of Hong Kong1
Xijing Hospital1
Zhu Mingjun1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronary Artery Disease11
Angina, Stable1
Atherosclerosis1
Coronary Disease1
Inflammation1
Ischemic Stroke1
Myocardial Ischemia1
Non-ST Elevated Myocardial Infarction1
Peripheral Arterial Disease1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.